We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comments, Opinions, and Brief Case Reports |

Desmopressin Test in Occult Eutopic Corticotropin Microadenoma

P. Chiodera, MD; R. Volpi, MD; M. Bianconcini, MD; M. L. Bortesi, MD; G. Manfredi, MD; V. Coiro, MD
Arch Intern Med. 2002;162(7):840-841. doi:10.1001/archinte.162.7.840.
Text Size: A A A
Published online


At an early stage, corticotroph microadenomas may sometimes remain undetected in patients with Cushing syndrome, even after examination with the most advanced diagnostic techniques, such as magnetic resonance imaging (MRI) and simultaneous bilateral petrosal sinus sampling. Therefore, occult eutopic corticotropin secretion may be misinterpreted as ectopic corticotropin production.

Recently, the peptide desmopressin (a vasopressin analog acting at hypothalamic-pituitary level) has been found to induce corticotropin hyperresponsiveness through specific receptor pathways in patients with the pituitary-dependent form of Cushing disease.1,2 We now report on a patient with developing pituitary corticotropin-dependent Cushing syndrome in whom MRI and bilateral catheterization of the inferior petrosal sinuses were unable to identify the pituitary autonomous corticotropin-secreting microadenoma. Therefore, the patient was tested with desmopressin to establish whether this test represents a precocious and sensitive method to identify a pituitary source of autonomous corticotropin secretion.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Circulating concentrations of corticotropin (A) and cortisol (B) after intravenous desmopressin administration. Error bars represent SE.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

3 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles